Come join others currently navigating treatment in our weekly Zoom Meetup! Register here: Tuesdays, 1pm ET.
Kadcyla Continues to Improve Survival in HER2-Positive Early-Stage Breast Cancer
moderators
Posts: 8,633
Kadcyla Continues to Improve Survival in HER2-Positive Early-Stage Breast Cancer
Dec 17, 2023
More than eight years of follow-up from the KATHERINE trial showed the continued survival benefits of Kadcyla over Herceptin for HER2-positive breast cancer with a high risk of recurrence. Read more…
0
Categories
Join Us on Zoom: Upcoming virtual meetups. Read more...
Give your account some personality! Add a profile photo.